Blood Transfusion Devices Market Size, Share, Growth, Outlook, and Opportunity Analysis, Forecast 2020 - 2027
![]() |
The process of transferring blood products into one's circulation intravenously is known as blood transfusion. Transfusions are used to replace lost blood components in a variety of medical conditions.
The number of different types of surgeries has increased dramatically in recent years in all parts of the world. C-section procedures, cardiovascular procedures, trauma, and accident injuries are just a few of the key surgical procedures that require a lot of blood transfusion. As a result of the increase in the number of the aforementioned types of surgeries, the global blood transfusion devices market is expected to experience an upward demand curve during the assessment period. One of the major factors driving demand opportunities in the Blood Transfusion Devices Market is the increasing occurrence of various types of chronic blood-related diseases such as lymphoma and leukaemia. Aside from that, the rising prevalence of kidney diseases is expected to generate massive sales opportunities in the blood transfusion device market in the coming years.
Cardiovascular procedures, C-section procedures, and trauma and accident injuries are among the most common surgeries that necessitate blood transfusions. According to NIH and National Heart, Lung, and Blood Institute estimates, blood transfusions are very common in the United States, with over 5 million Americans requiring blood transfusions each year, increasing the demand for blood transfusion devices.
Market Segmentation:
By Product Type
- Apheresis Systems
- Infusion Devices
- Blood Warmers
- Venous Access Devices
- Filters
- Others
- Hospital
- Ambulatory Surgical Centers
- Others
The key players operating in the blood transfusion devices market include Fresenius Kabi AG, Grifols, S.A., Tenko International Group Corp, Terumo Corporation, Kawasumi Laboratories, Inc., Haemonetics Corporation, Bioelectronica MILANO, RAYS S.P.A., Macopharma SA, B. Braun Melsungen AG, Baxter International Inc., Neomedic Limited, and 3M Company.
Comments
Post a Comment